EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Characterization of a Novel PET Tracer for Noninvasive Evaluation of FGL1 Status in Tumors

Siyi Tan, Xiang Ding, Donghui Pan, Yue Xu, Ce Wang, Junjie Yan iD, Chongyang Chen, Lizhen Wang, Xinyu Wang iD, Min Yang iD, Yuping Xu

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Siyi Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing Medical University, Nanjing 211166, China. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Gallium Radioisotopes, Radiopharmaceuticals. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Wuxi Municipal Bureau on Science and Technology, Jiangsu Commission of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrinogen-like protein 1 (FGL1) is a potential novel immune checkpoint target for malignant tumor diagnosis and therapy. Accurate detection of FGL1 levels in tumors via noninvasive PET imaging might be beneficial for managing the disease. To achieve this, multiple FGL1-targeting peptides (FGLP) were designed, and a promising candidate, 68Ga-NOTA-FGLP2, was identified through a high-throughput screening approach using microPET imaging of 68Ga-labeled peptides. Subsequent in vitro cell experiments showed that uptake values of 68Ga-NOTA-FGLP2 in FGL1 positive Huh7 tumor cells were significantly higher than those in FGL1 negative U87 MG tumor cells. Further microPET imaging showed that the Huh7 xenografts were clearly visualized with a favorable contrast. ROI analysis showed that the uptake values of the tracer in Huh7 xenografts were 2.63 ± 0.07% ID/g at 30 min p.i.. After treatment with an excess of unlabeled FGLP2, the tumor uptake significantly decreased to 0.54 ± 0.05% ID/g at 30 min p.i.. Moreover, the uptake in U87 MG xenografts was 0.44 ± 0.06% ID/g at the same time point. The tracer was excreted mainly through the renal system. 18F-FDG PET imaging was also performed in mice bearing Huh7 and U87 MG xenografts, respectively. However, there was no significant difference in the uptake between the tumors with different FGL1 expressions. Preclinical data indicated that 68Ga-NOTA-FGLP2 might be a suitable radiotracer for in vivo noninvasive visualization of tumors with abundant expression of FGL1. Further investigation of 68Ga-NOTA-FGLP2 for tumor diagnosis and therapy is undergoing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyGallium RadioisotopesRadiopharmaceuticalsAnimalsHumansMiceCell Line, TumorMice, NudeTissue DistributionPeptidesMice, Inbred BALB CFemaleHeterocyclic Compounds, 1-Ring

Stichwörter der Autor:innen

FGL1immune checkpoint inhibitorpositron emission tomography (PET)tumor

Substanzen

Gallium RadioisotopesRadiopharmaceuticalsPeptides1,4,7-triazacyclononane-N,N',N''-triacetic acidHeterocyclic Compounds, 1-Ring

Autor:innen und Institutionen

  • School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
  • Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China.

ORCID-Profile: Junjie Yan, Xinyu Wang, Min Yang

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Wuxi Municipal Bureau on Science and Technology
  • Jiangsu Commission of Health

Zitieren

APA

Tan, S., Ding, X., Pan, D., Xu, Y., Wang, C., Yan, J., Chen, C., Wang, L., Wang, X., Yang, M., & Xu, Y. (2024). Synthesis and Characterization of a Novel PET Tracer for Noninvasive Evaluation of FGL1 Status in Tumors. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00137

Vancouver

Tan S, Ding X, Pan D, Xu Y, Wang C, Yan J, et al. Synthesis and Characterization of a Novel PET Tracer for Noninvasive Evaluation of FGL1 Status in Tumors. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00137

BibTeX
@article{Tan2024,
  author = {Tan, Siyi and Ding, Xiang and Pan, Donghui and Xu, Yue and Wang, Ce and Yan, Junjie and Chen, Chongyang and Wang, Lizhen and Wang, Xinyu and Yang, Min and Xu, Yuping},
  title = {Synthesis and Characterization of a Novel PET Tracer for Noninvasive Evaluation of FGL1 Status in Tumors},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00137}
}
Kostenlos starten →